FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to dermatology and psychiatry, and concerns psychoemotional state correction in the patients with chronic dermatoses. That is ensured by the administration of Phrenolon 1/4 - 1/2 tablets in the morning, Amitriptyline 1/2 tablets in the afternoon and 1 tablet in the evening or every night at bedtime in the psychotic patients; therapeutic course is 1-1.5 weeks. In the neurotic patients, Phrenolon 1/2 tablets in the morning and in the evening, Amitriptyline 1/2 tablets in the afternoon and in the evening, Chlorprothixene 1/2 tablets in the evening and 1 tablet every night at bedtime; therapeutic course is 1-1,5 weeks.
EFFECT: method ensures the effective correction of psychoemotional state in the patients with chronic dermatoses with considering psychoemotional characteristics.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR COMPLEX EXPOSURE ON NEURAL-REFLEX ITCHING MECHANISMS IN PATIENTS WITH ATOPIC DERMATITIS | 2013 |
|
RU2523634C1 |
METHOD OF TREATMENT OF WITHDRAWAL SYNDROME WITH ALCOHOLISM AND DRUG ADDICTION | 2017 |
|
RU2648359C1 |
METHOD FOR THE TREATMENT OF WITHDRAWAL PSYCHOSIS IN PERSONS WITH DEPENDENCE ON SEDATIVES AND HYPNOTICS BELONGING TO THE GROUP OF SYNTHETIC AGONISTS OF GAMMA-AMINOBUTYRIC ACID RECEPTORS, BUTYROLACTONE AND 1,4-BUTANEDIOL | 2022 |
|
RU2788894C1 |
METHOD FOR TREATMENT OF PATIENTS WITH LICHEN PLANUS | 2016 |
|
RU2629601C1 |
METHOD OF TREATING VIDAL'S DISEASE | 2008 |
|
RU2396963C1 |
METHOD OF TREATING CHRONIC INFLAMMATORY DERMATOSES IN CHILDREN | 1998 |
|
RU2175244C2 |
METHOD OF TREATMENT OF PATIENTS WITH PSYCHOGENIC AND SOMATOGENIC BOUNDARY PSYCHIC DISORDERS | 1995 |
|
RU2121348C1 |
METHOD FOR TREATING ATYPICAL FORM OF PSORIASIS | 2000 |
|
RU2200594C2 |
METHOD FOR TREATMENT OF PATIENTS WITH ROSACEA | 2022 |
|
RU2787970C1 |
METHOD FOR OUTPATIENT TREATMENT OF FACIAL SKIN OF PATIENTS WITH ROSACEA | 2015 |
|
RU2577297C1 |
Authors
Dates
2010-09-27—Published
2009-02-09—Filed